Chemoimmunotherapy with brentuximab vedotin combined with ifosfamide, gemcitabine, and vinorelbine is highly active in relapsed or refractory classical Hodgkin lymphoma.
作者信息
Abuelgasim Khadega A, Alzahrani Mohsen, Alsharhan Yousef, Khairi Moataz, Hommady Mohammed, Gmati Giamal, Salama Hind, Ali Osama, Alahmari Bader, Masuadi Emad M, Alaskar Ahmed, Alhejazi Ayman, Damlaj Moussab
机构信息
King Abdulla International Medical Research Center, Riyadh, Saudi Arabia.
King Abdulaziz Medical City, Department of Oncology, Riyadh, Saudi Arabia.
出版信息
Bone Marrow Transplant. 2019 Jul;54(7):1168-1172. doi: 10.1038/s41409-019-0454-z. Epub 2019 Jan 30.
Abstract
摘要
Zotero 插件